Pharmacology · 2000 · 15 citations · 14 references
Life SciencesPharmacologyCell SignalingMolecular PharmacologySignal TransductionCirculatory PhysiologyReceptor PharmacologyCalcitonin Gene-related Peptide AntagonistsCalcitonin Gene-related Peptide PhysiologyVasodilator Pharmacology
Human adrenomedullin (AM) and human calcitonin gene-related peptide (CGRP) produced a concentration-dependent relaxation in mouse aorta, precontracted with noradrenaline. EC(50) values for AM and CGRP were 9.8 +/- 2.4 and 4.2 +/- 0.1 nmol/l, respectively. AM-mediated vasorelaxation was partially (3-fold) shifted by AM(22-52), the C-terminal AM fragment, but not by CGRP(8-37), a selective CGRP1 antagonist. Both AM(22-52) and CGRP(8-37) failed to inhibit CGRP-mediated vasorelaxation of mouse aorta rings. Binding of rat [(125)I]AM to these membranes was specific. Both human AM and AM(22-52) displaced rat [(125)I]AM binding in a concentration-dependent manner with IC(50) values of 12.0 +/- 4 and 19.4 +/- 8 nmol/l, respectively. In contrast, both human CGRP and CGRP(8-37) were weak in displacing [(125)I]AM binding. Very little specific binding was observed with [(125)I]CGRP. In conclusion, the data presented here demonstrate that the mouse aorta displays AM receptors that mediate vasorelaxation.
14
An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat.
A. A. Owji, David M. Smith, H. A. Coppock et al. · Endocrinology · 1995 · 300 citations
Medicine, Biochemistry, Pharmacology +15